{
  "schema_version": 2,
  "updated": "2026-01-13",
  "categories": [
    "syndrome",
    "formula",
    "herb",
    "compound",
    "therapy"
  ],
  "notes_zh": "本证据库用于肿瘤支持治疗与整合医学教育，不替代标准肿瘤治疗。请将所有草药/补充剂与肿瘤团队沟通，关注相互作用与安全监测。",
  "notes_en": "Educational integrative oncology library; not a substitute for standard cancer care. Discuss all herbs/supplements with the oncology team and monitor safety/interactions.",
  "refs_library": [
    {
      "title": "Unconventional Treatments for Pancreatic Cancer: A Systematic Review",
      "journal": "Cancers",
      "year": 2025,
      "doi": "10.3390/cancers17091437",
      "url": "https://doi.org/10.3390/cancers17091437",
      "source_file": "cancers-17-01437.pdf"
    },
    {
      "title": "Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery",
      "journal": "Molecular Cancer",
      "year": 2024,
      "doi": "10.1186/s12943-024-02136-2",
      "url": "https://doi.org/10.1186/s12943-024-02136-2",
      "source_file": "s12943-024-02136-2.pdf"
    },
    {
      "title": "Clinical Study of 32 Patients with Advanced Pancreatic Cancer Treated with Traditional Chinese Medicine Combined with Chemotherapy",
      "journal": "Alternative Therapies in Health and Medicine",
      "year": 2024,
      "citation": "Altern Ther Health Med. 2024;30(12):150-153",
      "url": null,
      "source_file": "Clinical_Study_of_32_Patients_.pdf"
    },
    {
      "title": "Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach",
      "journal": "Frontiers in Microbiology",
      "year": 2023,
      "doi": "10.3389/fmicb.2023.1231503",
      "url": "https://doi.org/10.3389/fmicb.2023.1231503",
      "source_file": "fmicb-14-1231503.pdf"
    }
  ],
  "items": [
    {
      "id": "therapy_integrative_chemo_checklist",
      "type": "therapy",
      "evidence_level": "moderate",
      "name_zh": "化疗期中西医合用：安全核对清单",
      "name_en": "Chemo + TCM: Safety Checklist",
      "summary_zh": "用于化疗/放疗期间考虑使用中药、草本或补充剂时的沟通与监测要点：明确目标（减轻毒副反应/改善食欲/睡眠），记录所有成分与剂量；关注肝肾功能、凝血、感染风险与过敏；避免来源不明产品；出现发热、黄疸加重、严重腹泻/出血等红旗症状应立即就医。",
      "summary_en": "Key communication and monitoring points when considering herbs/supplements during chemo/radiation: define goals, document all ingredients/doses, monitor liver/kidney function and bleeding/infection risk, avoid unknown products; seek urgent care for red flags (fever, worsening jaundice, severe diarrhea/bleeding).",
      "use_cases": [
        "化疗期辅助管理",
        "用药安全",
        "医患沟通"
      ],
      "stage": [
        "chemo"
      ],
      "components": {},
      "risks": [
        "血小板低下/抗凝治疗/肝肾功能异常者需格外谨慎",
        "避免替代标准抗肿瘤治疗"
      ],
      "interactions": [
        "与抗凝/抗血小板药、部分靶向药或免疫治疗可能存在相互作用；需由肿瘤团队评估"
      ],
      "refs": [
        {
          "title": "Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery",
          "journal": "Molecular Cancer",
          "year": 2024,
          "doi": "10.1186/s12943-024-02136-2",
          "url": "https://doi.org/10.1186/s12943-024-02136-2",
          "source_file": "s12943-024-02136-2.pdf"
        },
        {
          "title": "Unconventional Treatments for Pancreatic Cancer: A Systematic Review",
          "journal": "Cancers",
          "year": 2025,
          "doi": "10.3390/cancers17091437",
          "url": "https://doi.org/10.3390/cancers17091437",
          "source_file": "cancers-17-01437.pdf"
        }
      ]
    },
    {
      "id": "therapy_unconventional_overview_pcc",
      "type": "therapy",
      "evidence_level": "moderate",
      "name_zh": "胰腺癌“非常规/替代疗法”证据概览（谨慎）",
      "name_en": "Unconventional/Alternative Treatments in Pancreatic Cancer (Evidence Overview)",
      "summary_zh": "系统综述总结了胰腺癌相关“非常规疗法”的临床研究，整体证据质量参差且异质性高。用于临床沟通时应强调：任何补充/替代疗法不应延误标准治疗；若作为支持治疗需关注安全性、药物相互作用与真实终点（OS/PFS/QoL）。",
      "summary_en": "A systematic review summarizes clinical studies on unconventional treatments in pancreatic cancer; evidence is heterogeneous and variable. Key message: do not delay standard care; if used as supportive care, focus on safety, drug interactions and patient-relevant outcomes (OS/PFS/QoL).",
      "use_cases": [
        "专家沟通",
        "证据总结",
        "风险提示"
      ],
      "stage": [
        "general",
        "chemo",
        "recovery"
      ],
      "components": {},
      "risks": [
        "信息误导风险；避免使用夸大疗效的产品/疗法"
      ],
      "interactions": [
        "部分草本/补充剂可能影响凝血或肝酶，从而影响治疗安全"
      ],
      "refs": [
        {
          "title": "Unconventional Treatments for Pancreatic Cancer: A Systematic Review",
          "journal": "Cancers",
          "year": 2025,
          "doi": "10.3390/cancers17091437",
          "url": "https://doi.org/10.3390/cancers17091437",
          "source_file": "cancers-17-01437.pdf"
        }
      ]
    },
    {
      "id": "therapy_tcm_plus_chemo_32patients",
      "type": "therapy",
      "evidence_level": "low",
      "name_zh": "中医药联合化疗（32例临床研究）",
      "name_en": "TCM Combined with Chemotherapy (32‑patient clinical study)",
      "summary_zh": "单中心临床研究：晚期胰腺癌患者接受“中医药联合化疗”与仅化疗对照比较。文中报道联合组中医证候评分改善、生活质量提高，且不良反应发生率更低。局限：样本量小、单中心、干预细节与标准化程度有限，需更高质量研究验证。",
      "summary_en": "Single-center clinical study comparing TCM+chemo vs chemo alone in advanced pancreatic cancer. Reported improvements in TCM symptom scores and QoL, with lower adverse-event rates in the combined group. Limitations: small sample, single center, limited standardization; higher-quality trials needed.",
      "use_cases": [
        "生活质量改善",
        "减轻化疗相关不适（支持治疗）"
      ],
      "stage": [
        "chemo"
      ],
      "components": {},
      "risks": [
        "研究层级有限；具体方药/剂量需在专业医师监管下个体化"
      ],
      "interactions": [
        "化疗期间需监测肝肾功能与骨髓抑制；用药清单需与肿瘤团队共享"
      ],
      "refs": [
        {
          "title": "Clinical Study of 32 Patients with Advanced Pancreatic Cancer Treated with Traditional Chinese Medicine Combined with Chemotherapy",
          "journal": "Alternative Therapies in Health and Medicine",
          "year": 2024,
          "citation": "Altern Ther Health Med. 2024;30(12):150-153",
          "url": null,
          "source_file": "Clinical_Study_of_32_Patients_.pdf"
        }
      ]
    },
    {
      "id": "formula_huaier_granule",
      "type": "formula",
      "evidence_level": "low",
      "name_zh": "槐耳颗粒（Huaier Granule）",
      "name_en": "Huaier Granule",
      "summary_zh": "综述提及其在肝胆胰相关肿瘤临床研究中的应用，常作为辅助/支持治疗探索。对胰腺癌的证据多来自小样本或间接证据，需谨慎解读；若使用应关注产品来源与肝肾监测。",
      "summary_en": "Referenced in clinical studies in hepatobiliary-related cancers as an adjunct/supportive therapy. Evidence specific to pancreatic cancer is limited or indirect; interpret cautiously and monitor product quality and organ function.",
      "use_cases": [
        "辅助/支持治疗探索"
      ],
      "stage": [
        "chemo",
        "recovery",
        "general"
      ],
      "components": {},
      "risks": [
        "证据外推风险；避免替代标准治疗"
      ],
      "interactions": [
        "与化疗合用需监测肝功能与过敏反应"
      ],
      "refs": [
        {
          "title": "Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery",
          "journal": "Molecular Cancer",
          "year": 2024,
          "doi": "10.1186/s12943-024-02136-2",
          "url": "https://doi.org/10.1186/s12943-024-02136-2",
          "source_file": "s12943-024-02136-2.pdf"
        }
      ]
    },
    {
      "id": "formula_huachansu",
      "type": "formula",
      "evidence_level": "low",
      "name_zh": "华蟾素（Huachansu）",
      "name_en": "Huachansu",
      "summary_zh": "综述中作为临床研究中出现的中医药制剂之一。临床证据与适应证需以具体试验为准；潜在心律/电解质相关风险需评估，建议仅在医疗监管下使用。",
      "summary_en": "Listed among TCM therapeutics appearing in clinical trials. Indications and benefit/risk should follow specific trials; potential cardiac/electrolyte risks warrant medical supervision.",
      "use_cases": [
        "辅助治疗研究",
        "症状支持"
      ],
      "stage": [
        "chemo"
      ],
      "components": {},
      "risks": [
        "潜在心脏相关不良反应风险；禁用于来源不明制剂"
      ],
      "interactions": [
        "与影响心律或电解质的药物合用需谨慎"
      ],
      "refs": [
        {
          "title": "Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery",
          "journal": "Molecular Cancer",
          "year": 2024,
          "doi": "10.1186/s12943-024-02136-2",
          "url": "https://doi.org/10.1186/s12943-024-02136-2",
          "source_file": "s12943-024-02136-2.pdf"
        }
      ]
    },
    {
      "id": "compound_icaritin",
      "type": "compound",
      "evidence_level": "low",
      "name_zh": "依卡替尼（Icaritin，天然产物衍生物）",
      "name_en": "Icaritin (natural product-derived compound)",
      "summary_zh": "综述提及其在肝胆胰系统肿瘤的临床研究与药物发现价值。对胰腺癌的临床证据需以具体试验为准；作为药物/成分应关注药代与肝功能监测。",
      "summary_en": "Review highlights clinical evidence and drug-discovery potential in hepatobiliary system cancers. Pancreatic-cancer-specific clinical evidence depends on individual trials; monitor pharmacokinetics and liver function.",
      "use_cases": [
        "药物发现/临床研究条目"
      ],
      "stage": [
        "chemo",
        "general"
      ],
      "components": {},
      "risks": [
        "作为药物级干预需遵循试验/处方规范"
      ],
      "interactions": [
        "可能与肝酶代谢相关药物相互作用，需监测"
      ],
      "refs": [
        {
          "title": "Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery",
          "journal": "Molecular Cancer",
          "year": 2024,
          "doi": "10.1186/s12943-024-02136-2",
          "url": "https://doi.org/10.1186/s12943-024-02136-2",
          "source_file": "s12943-024-02136-2.pdf"
        }
      ]
    },
    {
      "id": "herb_ginseng",
      "type": "herb",
      "evidence_level": "low",
      "name_zh": "人参（Panax ginseng）",
      "name_en": "Ginseng (Panax ginseng)",
      "summary_zh": "作为补充/草本使用较常见，研究多聚焦疲劳、食欲与生活质量等支持性结局；证据质量不一。化疗/免疫治疗期间使用需评估相互作用与血糖、血压影响。",
      "summary_en": "Commonly used supplement; studies focus on supportive outcomes (fatigue, appetite, QoL) with variable quality. During chemo/immunotherapy, assess interactions and effects on glucose/blood pressure.",
      "use_cases": [
        "乏力",
        "食欲",
        "支持治疗"
      ],
      "stage": [
        "chemo",
        "recovery"
      ],
      "components": {},
      "risks": [
        "可能影响血糖/血压；来源与剂量不确定风险"
      ],
      "interactions": [
        "可能影响免疫调节或CYP代谢通路；用药清单需共享"
      ],
      "refs": [
        {
          "title": "Unconventional Treatments for Pancreatic Cancer: A Systematic Review",
          "journal": "Cancers",
          "year": 2025,
          "doi": "10.3390/cancers17091437",
          "url": "https://doi.org/10.3390/cancers17091437",
          "source_file": "cancers-17-01437.pdf"
        }
      ]
    },
    {
      "id": "compound_curcumin",
      "type": "compound",
      "evidence_level": "very_low",
      "name_zh": "姜黄素（Curcumin）",
      "name_en": "Curcumin",
      "summary_zh": "多为机制与前临床研究；胰腺癌临床证据有限。作为补充剂高剂量可能增加出血风险或加重胃肠道不适；化疗期不建议自行大剂量使用。",
      "summary_en": "Mostly mechanistic and preclinical evidence; limited clinical data in pancreatic cancer. High-dose supplementation may increase bleeding risk or GI upset; avoid self-prescribed high doses during chemo.",
      "use_cases": [
        "补充剂讨论",
        "机制研究"
      ],
      "stage": [
        "chemo",
        "general"
      ],
      "components": {},
      "risks": [
        "出血风险、胃刺激"
      ],
      "interactions": [
        "与抗凝/抗血小板药物合用需谨慎"
      ],
      "refs": [
        {
          "title": "Unconventional Treatments for Pancreatic Cancer: A Systematic Review",
          "journal": "Cancers",
          "year": 2025,
          "doi": "10.3390/cancers17091437",
          "url": "https://doi.org/10.3390/cancers17091437",
          "source_file": "cancers-17-01437.pdf"
        }
      ]
    },
    {
      "id": "therapy_phage_peptide_targeting",
      "type": "therapy",
      "evidence_level": "low",
      "name_zh": "噬菌体展示肽靶向策略（研究进展，非TCM）",
      "name_en": "Phage-display peptide targeting (research, non-TCM)",
      "summary_zh": "综述介绍噬菌体展示技术筛选高亲和力肽用于胰腺癌早期检测、靶向递送与治疗的研究进展。属于实验与转化研究方向，不属于中医药治疗；可作为“替代/创新策略”证据条目补充展示。",
      "summary_en": "Review describes phage display to identify high-affinity peptides for early detection, targeted delivery and treatment in pancreatic cancer. This is translational research (non-TCM) and included here as an innovation/alternative strategy reference.",
      "use_cases": [
        "研究进展",
        "早筛/靶向递送"
      ],
      "stage": [
        "general"
      ],
      "components": {},
      "risks": [
        "目前主要为研究阶段，临床可及性有限"
      ],
      "interactions": [
        "与临床治疗方案需由肿瘤团队评估"
      ],
      "refs": [
        {
          "title": "Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach",
          "journal": "Frontiers in Microbiology",
          "year": 2023,
          "doi": "10.3389/fmicb.2023.1231503",
          "url": "https://doi.org/10.3389/fmicb.2023.1231503",
          "source_file": "fmicb-14-1231503.pdf"
        }
      ]
    }
  ]
}